<DOC>
	<DOCNO>NCT01018680</DOCNO>
	<brief_summary>The study test hypothesis , patient knee pain due osteoarthritis ( OA ) take nonsteroidal anti-inflammatory drug ( NSAIDs ) still significant knee pain , duloxetine 60 120 milligram ( mg ) daily 10 week provide additional reduction pain .</brief_summary>
	<brief_title>A Study Comparing Duloxetine Versus Placebo Patients Taking Nonsteroidal Anti-inflammatory Drug ( NSAID ) Knee Pain Due Osteoarthritis</brief_title>
	<detailed_description>Duloxetine study pain due osteoarthritis ( OA ) 2 previous placebo control clinical trial . In clinical practice , nonsteroidal anti-inflammatory drug ( NSAIDs ) ineffective reduce pain due OA , clinician often add second agent without discontinue NSAIDs . In study , investigate whether add duloxetine NSAIDs provide additional pain relief functional improvement patient knee pain due OA .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Present knee pain due osteoarthritis ( OA ) base OA clinical radiographic diagnostic criterion . Knee Pain &gt; 14 day month 3 month directly precede study entry . Taking nonsteroidal antiinflammatory drug ( NSAIDs ) knee pain due OA day 3 month immediately precede study entry . History intolerance nonresponsiveness adequate trial duloxetine use indication , opinion investigator . Previous diagnosis psychosis , bipolar disorder , schizoaffective disorder . Have major depressive disorder ( MDD ) determine use depression module Mini International Neuropsychiatric Interview ( MINI ) . Judged clinically investigator suicidal risk examination use Columbia Suicide Severity Rating Scale ( CSSRS ) . History substance abuse dependence within past year , exclude nicotine caffeine . Positive urine drug screen substance abuse exclude medication . Opioid dependent opinion investigator , take opioids 3 day week , unwilling discontinue opioids study period . Known hypersensitivity duloxetine inactive ingredient . History intolerance hypersensitivity NSAIDS , Cyclooxygenase ( COX2 ) inhibitor , proton pump inhibitor . History peptic ulcer disease , bleed disorder , gastrointestinal bleeding , abnormal bleeding . Baseline hemoglobin measurement &lt; 11 gram per deciliter ( g/dL ) male , &lt; 10 g/dL female . Serious unstable cardiovascular , hepatic , renal , metabolic , respiratory , hematologic illness , symptomatic peripheral vascular disease , medical psychiatric condition would compromise participation likely lead hospitalization change medication course study . Uncorrected thyroid disease , uncontrolled narrowangle glaucoma , uncontrolled poorly control hypertension , history seizure . Active liver injury ( hepatitis ) degree hepatic insufficiency ( ChildPugh Class C ) . Frequent fall could result hospitalization could compromise response treatment . Confounding painful condition may interfere assessment index knee . Chronic widespread pain affect four quadrant body , diagnosis fibromyalgia . Received intraarticular hyaluronate ( Synvisc ) , steroid , joint lavage , invasive therapy knee past 6 month . Arthroscopy index knee within past year joint replacement index knee anytime . Diagnosis inflammatory arthritis ( , rheumatoid arthritis , psoriatic arthritis , reactive arthritis , ankylose spondylitis , etc . ) autoimmune disorder ( exclude inactive Hashimoto 's thyroiditis ) . Prior synovial fluid analysis show white blood cell count great equal 2000 cubic millimeter ( mm^3 ) indicative diagnosis OA , history gout pseudogout . Radiographic evidence endstage ( bone bone ) OA either knee . Knee replacement surgery plan within next 6 month . Nonambulatory require use crutch , walker , 1 cane . Body mass index ( BMI ) &gt; 40 .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>